🏛️ Verified NIH Record • Updated 2026-05-28
Psorcast Mobile Study (NCT05621369)
Psorcast Study: A Smartphone-based Study of Psoriasis and Psoriatic Arthritis
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Sage Bionetworks
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to understand variation in the symptoms of psoriasis and psoriatic arthritis using simple, scalable smartphone-based measurements. This study uses an iPhone app to record these symptoms through questionnaires and sensors.
Who can join: Review the eligibility criteria below.
Location: Sage Bionetworks — Seattle, Washington
Age range: 18 Years
🧪 Interventions in This Study
- Participant self-assessment surveys (BEHAVIORAL)
- Psoriasis Draw (BEHAVIORAL)
- Psoriasis Area Photo (BEHAVIORAL)
- Finger and Toe Photos (BEHAVIORAL)
- Digital Jar Open (BEHAVIORAL)
- 30 Second Walk (BEHAVIORAL)
- Psorcast mobile application (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Sage Bionetworks — Seattle, Washington
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Psoriatic Arthritis
- A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs — Gilbert, Arizona
- Psoriatic Arthritis D2P Screening — Philadelphia, Pennsylvania
- Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis — Dothan, Alabama
- Apremilast Pregnancy Exposure Registry — La Jolla, California
- A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy — Anniston, Alabama
Explore by condition: All Psoriatic Arthritis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.